Partnering with pharmacists ensures prescription availability for patients with HIV during the coronavirus disease 2019 (COVID-19), noted Milena Murray, PharmD, MSc, BCIDP, AAHIVP, of Midwestern University College of Pharmacy.
Partnering with community pharmacists helps to ensure patients can pick up their prescriptions, especially if there are fill issues at our specialty pharmacy, noted Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University Chicago College of Pharmacy, who practices at the Northwestern Medicine Infectious Disease Center in Chicago.
Transcript
How have your patient interactions changed now that the HIV epidemic overlaps with the coronavirus disease 2019 pandemic?
There’s so much more phone interaction. So, a lot of the times the patients aren’t coming into the clinic and we’re calling them on the phone, whether it’s for an adherence check or counseling, or whatever it may be. And that’s really helpful, because then we can touch base serially with the patient and we’re not waiting for them to come to us.
How do your responsibilities differ from those of a more generalized community pharmacist?
As an ambulatory care pharmacist, partnering with community pharmacies and pharmacists is so important, because that’s the point of dispense if the patients aren’t able to fill at our specialty pharmacy, so I really get involved before the prescription goes out. So, are there drug interactions? Patient preferences? Is the tablet too large for them to swallow? And any other criteria. And then on the community side, they’re more involved after the prescription has been sent.
And so, we try to partner with them then to make sure, what was the co-pay? Did it go through the insurance? Is there a prior authorization need? And then, at that point, the patient would be able to pick up the prescription.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More